Quantification of hepcidin-25 in human cerebrospinal fluid using LC-MS/MS

被引:13
作者
Delaby, Constance [1 ]
Bros, Pauline [1 ,2 ]
Vialaret, Jerome [1 ]
Moulinier, Amandine [1 ]
Delatour, Vincent [2 ]
Gabelle, Audrey [1 ]
Lehmann, Sylvain [1 ]
Hirtz, Christophe [1 ]
机构
[1] CHU Montpellier, Inst Med Regenerat & Biotherapies LBPC IRMB, Lab Biochim & Proteom Clin, F-34250 Montpellier, France
[2] LabNatl Metrol & Essais LNE, F-75015 Paris, France
关键词
cerebrospinal fluid; hepcidin-25; LC-MS/MS; MS; neurological disorders; IRON-METABOLISM; ROUND-ROBIN; SERUM; URINE; EXPRESSION; ASSAY;
D O I
10.4155/bio-2016-0240
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Aim: Hepcidin, the main iron metabolism regulator, can be detected in various biological fluids. Here, we describe a quantitative method of LC-MS/MS to quantify the 25 amino acid isoform of hepcidin (hepcidin-25) in human cerebrospinal fluid (CSF). Results & methodology: Samples were prepared through protein precipitation followed by solid phase extraction (SPE) and injected into a triple-quadrupole mass spectrometer. Validation of our method included determination of LOQ (0.1 ng/ml), repeatability, intermediate precision, recovery and linearity (up to 25 ng/ml). Hepcidin-25 was subsequently quantified in 36 human CSF samples and its concentration ranged from 0.21 to 3.54 ng/ml. Conclusion: This is the first time that hepcidin-25 can be reliably quantified in human CSF. This may open interesting perspectives for the management of iron-related neurological disorders.
引用
收藏
页码:337 / 347
页数:11
相关论文
共 23 条
  • [1] Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH
    Bekri, Soumeya
    Gual, Philippe
    Anty, Rodolphe
    Luciani, Nathalie
    Dahman, Monsef
    Ramesh, Bala
    Iannelli, Antonio
    Staccini-Myx, Aline
    Casanova, Dominique
    Ben Amor, Imed
    Saint-Paul, Marie-Christine
    Huet, Pierre-Michel
    Sadoul, Jean-Louis
    Gugenheim, Jean
    Srai, Surjit Kaila S.
    Tran, Albert
    Le Marchand-Brustel, Yannick
    [J]. GASTROENTEROLOGY, 2006, 131 (03) : 788 - 796
  • [2] Bros P, 2015, FRONT NEUROSCI, V9, P1
  • [3] Is ferroportin-hepcidin signaling altered in restless legs syndrome?
    Clardy, Stacey L.
    Wang, Xinsheng
    Boyer, Philip J.
    Earley, Christopher J.
    Allen, Richard P.
    Connor, James R.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2006, 247 (02) : 173 - 179
  • [4] Delaby C., 2014, EuPA Open Proteomics, V3, P60, DOI DOI 10.1016/J.EUPR0T.2014.02.004
  • [5] Serum hepcidin assay in 2011: where do we stand?
    Delaby, Constance
    Beaumont, Carole
    [J]. ANNALES DE BIOLOGIE CLINIQUE, 2012, 70 (04) : 377 - 386
  • [6] Hepcidin Is Involved in Iron Regulation in the Ischemic Brain
    Ding, Hui
    Yan, Cai-Zhen
    Shi, Honglian
    Zhao, Ya-Shuo
    Chang, Shi-Yang
    Yu, Peng
    Wu, Wen-Shuang
    Zhao, Chen-Yang
    Chang, Yan-Zhong
    Duan, Xiang-Lin
    [J]. PLOS ONE, 2011, 6 (09):
  • [7] Hepcidin Directly Inhibits Transferrin Receptor 1 Expression in Astrocytes via a Cyclic AMP-Protein Kinase A Pathway
    Du, Fang
    Qian, Christopher
    Qian, Zhong Ming
    Wu, Xiao-Mei
    Xie, Hui
    Yung, Wing-Ho
    Ke, Ya
    [J]. GLIA, 2011, 59 (06) : 936 - 945
  • [8] Urinary Hepcidin-25 and Risk of Acute Kidney Injury Following Cardiopulmonary Bypass
    Ho, Julie
    Reslerova, Martina
    Gali, Brent
    Gao, Ang
    Bestland, Jennifer
    Rush, David N.
    Nickerson, Peter W.
    Rigatto, Claudio
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2011, 6 (10): : 2340 - 2346
  • [9] Hepcidin Revisited, Disulfide Connectivity, Dynamics, and Structure
    Jordan, John B.
    Poppe, Leszek
    Haniu, Mitsuru
    Arvedson, Tara
    Syed, Rashid
    Li, Vivian
    Kohno, Hiko
    Kim, Helen
    Schnier, Paul D.
    Harvey, Timothy S.
    Miranda, Les P.
    Cheetham, Janet
    Sasu, Barbra J.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (36) : 24155 - 24167
  • [10] Mass spectrometry-based hepcidin measurements in serum and urine: Analytical aspects and clinical implications
    Kemna, Erwin H. J. M.
    Tjalsma, Harold
    Podust, Vladimir N.
    Swinkels, Dorine W.
    [J]. CLINICAL CHEMISTRY, 2007, 53 (04) : 620 - 628